A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
NCT06977724
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Sjorgren's disease (SjD) is a chronic, multisystem autoimmune disease characterized by lacrimal and salivary gland inflammation, with resultant dryness of the eyes and mouth and occasional glandular enlargement and Rheumatoid arthritis (RA) is a long-lasting autoimmune disease that causes the body's immune system to attack itself. RA targets the body's joints, causing inflammation (swelling, pain, and redness).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Dry Eye Syndrome
- Systemic Lupus Erythematosus
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AbbVie
- Last updated on ClinicalTrials.gov
- August 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 2
- Life Clinical Trials - Colonial Drive - Margate /ID# 276050 · Margate, FL
- Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 275836 · Tampa, FL
Illinois · 1
- Advanced Quality Medical Research /ID# 278462 · Orland Park, IL
Tennessee · 1
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826 · Memphis, TN
Texas · 1
- Integrative Rheumatology of South Texas - Harlingen /ID# 276458 · Harlingen, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.